The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ardelyx Inc’s stock clocked out at $5.27, down -7.87% from its previous closing price of $5.72. In other words, the price has decreased by -$7.87 from its previous closing price. On the day, 4.75 million shares were traded. ARDX stock price reached its highest trading level at $5.78 during the session, while it also had its lowest trading level at $5.18.
Ratios:
To gain a deeper understanding of ARDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.03. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 11, 2024, Downgraded its rating to Neutral and sets its target price to $5.50 from $11 previously.
On July 02, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $15 to $7.
On April 05, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $14.Leerink Partners initiated its Outperform rating on April 05, 2024, with a $14 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when RAAB MICHAEL sold 25,000 shares for $5.38 per share. The transaction valued at 134,482 led to the insider holds 1,150,385 shares of the business.
MICHAEL G. RAAB bought 25,000 shares of ARDX for $134,480 on Nov 25 ’24. On Nov 20 ’24, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 7,366 shares for $4.79 each. As a result, the insider received 35,316 and left with 308,745 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1248220544 and an Enterprise Value of 1186684032. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.15 while its Price-to-Book (P/B) ratio in mrq is 7.89. Its current Enterprise Value per Revenue stands at 4.712 whereas that against EBITDA is -19.094.
Stock Price History:
Over the past 52 weeks, ARDX has reached a high of $10.13, while it has fallen to a 52-week low of $4.34. The 50-Day Moving Average of the stock is -7.77%, while the 200-Day Moving Average is calculated to be -19.11%.
Shares Statistics:
It appears that ARDX traded 3.95M shares on average per day over the past three months and 3481440 shares per day over the past ten days. A total of 236.89M shares are outstanding, with a floating share count of 227.84M. Insiders hold about 3.81% of the company’s shares, while institutions hold 61.53% stake in the company. Shares short for ARDX as of 1731628800 were 23308546 with a Short Ratio of 5.90, compared to 1728950400 on 22887200. Therefore, it implies a Short% of Shares Outstanding of 23308546 and a Short% of Float of 11.1899994.
Earnings Estimates
The stock of Ardelyx Inc (ARDX) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.06 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.16 and -$0.23 for the fiscal current year, implying an average EPS of -$0.19. EPS for the following year is -$0.17, with 6.0 analysts recommending between $0.2 and -$0.5.
Revenue Estimates
In the current quarter, 10 analysts expect revenue to total $108.57M. It ranges from a high estimate of $125.5M to a low estimate of $97.4M. As of the current estimate, Ardelyx Inc’s year-ago sales were $34.36MFor the next quarter, 10 analysts are estimating revenue of $83.33M. There is a high estimate of $120M for the next quarter, whereas the lowest estimate is $63.41M.
A total of 10 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $343M, while the lowest revenue estimate was $314.9M, resulting in an average revenue estimate of $326.05M. In the same quarter a year ago, actual revenue was $124.46MBased on 10 analysts’ estimates, the company’s revenue will be $401.16M in the next fiscal year. The high estimate is $543M and the low estimate is $295.72M.
